This Brigham and Women’s Hospital virtual symposium is designed for people living with atrial fibrillation and the families and caregivers who support them. Held on October 4, 2025, it explains AFib, treatment choices, stroke-prevention approaches, and practical concerns that arise during ongoing care. The program covers medicines, anticoagulation, catheter and hybrid ablation, and newer pulsed field techniques, alongside genetics, lifestyle, sleep apnea, wearable monitors, and emotional wellbeing. Faculty question-and-answer sessions provide a patient-focused setting for these subjects. Healthcare professionals may also find the program useful for understanding and discussing the questions patients bring to cardiovascular appointments.
Learning Objectives
- Describe the mechanisms, risk factors, genetics, and clinical presentations of atrial fibrillation, distinguishing between paroxysmal, persistent, and refractory AFib.
- Understand pharmacological treatment strategies for atrial fibrillation, including medications used for rate control, rhythm maintenance, and systemic anticoagulation.
- Compare catheter-based and surgical interventional options, including radiofrequency ablation, cryoballoon ablation, pulsed field ablation (PFA), and hybrid ablation techniques.
- Identify non-pharmacological stroke prevention strategies, including left atrial appendage occlusion devices.
- Evaluate the role of lifestyle interventions, management of co-existing obstructive sleep apnea, and the use of wearable digital cardiac monitors in long-term rhythm surveillance.
- Recognize and address the psychological impact, anxiety, and emotional challenges associated with living with atrial fibrillation.
The objectives are retained from the supplied description and are not a separately verified official list. This program supports education and informed discussion; it does not replace individualized medical assessment or treatment advice.
Topics
-
What is Atrial Fibrillation
-
What have we learned from studying the genetics of atrial fibrillation
-
Atrial Fibrillation Epidemiology and Lifestyle Modification – What is the evidence
-
Medications for Rate Control
-
Medications for Heart Rate and Rhythm Control
-
2025 Anticoagulation Update
-
Non-Pharmacologic Strategies to Reduce Stroke Risk in AF
-
Pulmonary Vein Isolation and Treatment of Paroxysmal AF
-
Catheter Ablation for Atrial Fibrillation, Part Deux – Persistent Atrial Fibrillation
-
New Ablation Strategies – Pulsed Field Ablation
-
A New Pulse on AFib Care – Comparing RF and PFA
-
Hybrid Ablation for Treatment of Refractory Atrial Fibrillation
-
Digital Care – Wearable Monitors for Atrial Fibrillation Surveillance
-
Understanding the Intersection: Obstructive Sleep Apnea & Atrial Fibrillation
-
Managing the Psychological Consequences of Atrial Fibrillation
-
Faculty Q&A Sessions (Block 1, Block 2, Block 3, and Block 4)
Presenters and Moderators
- Rachel Tripp, PA-C
- Mengyan (Ester) Li, PharmD, BCPS, CACP, RPh
- Bruce A. Koplan, MD, MPH
- Julie B. Shea, NP — Moderator
- Usha B. Tedrow, MD, MSc
- Victor Nauffal, MD
- Sunil Kapur, MD
- William Sauer — Moderator
- Alex Leverton, PA-C
- Paul C. Zei, MD, PhD
- Thomas M. Tadros, MD, MPH
- William H. Sauer, MD
- Julie Shea — Moderator
- David Benavides, MD
- Megan E. Antonellis, MHS, PA-C
- Margo C. Funk, MD, MA, FACLP




